Journal of Pharmacy and Pharmacology

Apolipoprotein A-I, Cyclodextrins and Liposomes as Potential Drugs for the Reversal of Atherosclerosis. A Review
pp. 731-761(31)
Authors: Dass C.R.; Jessup W.

Body Distribution of Poly-d-lactide–poly(ethylene glycol) Microspheres with Entrapped Leptospira interrogans Antigens Following Intravenous and Oral Administration to Guinea-pigs
pp. 763-770(8)
Authors: Li X.; Zhang Y.; Yan R.; Zhang M.; Yuan M.; deng X.; Huang Z.

A Human Oral-throat Cast Integrated with a Twin-stage Impinger for Evaluation of Dry Powder Inhalers
pp. 771-778(8)
Authors: Srichana T.; Martin* G.P.; Marriott* C.

Cytotoxicity and Teratogenicity of Chlorhexidine Diacetate Released from Hollow Nylon Fibres
pp. 779-784(6)
Authors: Ostad S.N.; Gard P.R.

Investigations of the In-vitro Metabolism of Three Opioid Tetrapeptides by Pancreatic and Intestinal Enzymes
pp. 785-795(11)
Authors: Krondahl E.; von Euler-Chelpin H.; Orzechowski A.; EkstrÖm G.; LennernÄs H.

Recombinant Factor VIII SQ — Stability of VIII:C in Homogenates from Porcine, Monkey and Human Subcutaneous Tissue
pp. 797-805(9)
Authors: Fatouros A.; Lidén Y.; SjÖstrÖm B.

Intravenous Formulations of the Enantiomers of Thalidomide: Pharmacokinetic and Initial Pharmacodynamic Characterization in Man
pp. 807-817(11)
Authors: Eriksson T.; BjÖrkman S.; Roth B.; HÖglund P.

Isolation and Identification of Three Potential Impurities of Pholcodine Bulk Drug Substance
pp. 819-829(11)
Authors: denk O.M.; Gray A.I.; Skellern G.G.; Watson D.G.

In-vitro In-vivo Correlation Models for Glibenclamide after Administration of Metformin/Glibenclamide Tablets to Healthy Human Volunteers
pp. 831-838(8)
Authors: Balan G.; Timmins P.; Greene D.S.; Marathe P.H.

Structure–Activity Relationships of Anthraquinones in the Decrease of Intestinal Motility
pp. 839-842(4)
Authors: Kuo D-H.; Kuo S-C.; Cheng† J-T.

The Effect of Progesterone on Spontaneous and Agonist-Evoked Contractions of the Rat Aorta and Portal Vein
pp. 843-849(7)
Authors: Mukerji M.S.; Leathard H.L.; Huddart H.

Effects of the Oral Administration of a ₃-Adrenergic Agonist on Lipid Metabolism in Alloxan-Diabetic Rats
pp. 851-856(6)
Authors: Milagro F.I.; MartÍnez J.A.

Inhibition of Vascular Smooth Muscle Tone by the H⁺, K⁺-ATPase Inhibitor SCH 28080
pp. 857-862(6)
Author: Rhoden K.J.

Effect of Iron(III) Chitosan Intake on the Reduction of Serum Phosphorus in Rats
pp. 863-874(12)
Authors: Baxter J.; Shimizu F.; Takiguchi Y.; Wada M.; Yamaguchi T.

The Ethanol-soluble Part of a Hot-water Extract from Artemisia iwayomogi Inhibits Liver Fibrosis Induced by Carbon Tetrachloride in Rats
pp. 875-881(7)
Authors: Park E-J.; Nan J-X.; Kim J-Y.; Kang H-C.; Choi J.H.; Lee S.J.; Lee B.H.; Kim S.J.; Lee J.H.; Kim Y.C.; Sohn D.H.

Antitumour Activity and Side Effects of Combined Treatment with Chitosan and Cisplatin in Sarcoma 180-Bearing Mice
pp. 883-890(8)
Authors: Kimura Y.; Onoyama M.; Sera T.; Okuda H.

Effect of Luffa echinata on Lipid Peroxidation and Free Radical Scavenging Activity
pp. 891-894(4)
Authors: Kumar V.P.; Shashidhara S.; Kumar M.M.; Sridhara B.Y.

In-vitro Inhibition of Human Erythrocyte Acetylcholinesterase by Salvia lavandulaefolia Essential Oil and Constituent Terpenes
pp. 895-902(8)
Authors: Perry N.S.L.; Houghton P.J.; Theobald A.; Jenner† P.; Perry‡ E.K.